Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Mesothelioma is a relatively rare tumour, however continued use of asbestos in the developing world means that worldwide incidence of mesothelioma is expected to continue to increase. Previously, the more invasive procedure techniques were reserved for thoracic surgeons or interventional radiologists, however the increasing use of ultrasound by general physicians has led to an associated expansion in the field of interventional pulmonology available for pleural disease including mesothelioma. Pleural biopsy histology is important in the diagnosis of mesothelioma, and there are various techniques for obtaining pleural biopsies available to the interventional pulmonologist. Evidence-based treatment of mesothelioma relates to chemotherapy/oncological options and supportive care, and the interventional pulmonologist has an important role in the control of symptoms and in pleural effusion control.

Original publication

DOI

10.21037/shc.2018.04.01

Type

Journal article

Journal

Shanghai Chest

Publication Date

01/04/2018

Volume

2